IDR 555.0
(-2.63%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 3.3 Billion IDR | 0.0% |
2022 | - IDR | -100.0% |
2021 | 2.38 Billion IDR | -43.43% |
2020 | 4.21 Billion IDR | 0.0% |
2019 | - IDR | 0.0% |
2018 | - IDR | 0.0% |
2017 | - IDR | 0.0% |
2016 | - IDR | 0.0% |
2015 | - IDR | 0.0% |
2014 | - IDR | 0.0% |
2013 | - IDR | 0.0% |
2012 | - IDR | -100.0% |
2011 | 252.98 Billion IDR | 7.26% |
2010 | 235.85 Billion IDR | 5.38% |
2009 | 223.81 Billion IDR | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | - IDR | 0.0% |
2024 Q1 | 3.3 Billion IDR | 0.0% |
2024 Q3 | - IDR | 0.0% |
2023 Q2 | 4.5 Billion IDR | 0.0% |
2023 Q1 | - IDR | 0.0% |
2023 FY | 3.3 Billion IDR | 0.0% |
2023 Q4 | 3.3 Billion IDR | 0.0% |
2023 Q3 | 3.3 Billion IDR | -26.73% |
2022 FY | - IDR | -100.0% |
2022 Q4 | - IDR | -100.0% |
2022 Q1 | 2.13 Billion IDR | -10.57% |
2022 Q3 | 1.42 Billion IDR | -4.93% |
2022 Q2 | 1.5 Billion IDR | -29.68% |
2021 Q2 | 2.82 Billion IDR | -17.25% |
2021 Q1 | 3.41 Billion IDR | -19.0% |
2021 FY | 2.38 Billion IDR | -43.43% |
2021 Q4 | 2.38 Billion IDR | -15.49% |
2021 Q3 | 2.82 Billion IDR | -0.14% |
2020 Q3 | - IDR | 0.0% |
2020 Q1 | - IDR | 0.0% |
2020 Q4 | 4.21 Billion IDR | 0.0% |
2020 FY | 4.21 Billion IDR | 0.0% |
2020 Q2 | - IDR | 0.0% |
2019 Q1 | - IDR | 0.0% |
2019 FY | - IDR | 0.0% |
2019 Q3 | - IDR | 0.0% |
2019 Q2 | - IDR | 0.0% |
2019 Q4 | - IDR | 0.0% |
2018 FY | - IDR | 0.0% |
2018 Q4 | - IDR | 0.0% |
2018 Q3 | - IDR | 0.0% |
2018 Q2 | - IDR | 0.0% |
2018 Q1 | - IDR | 0.0% |
2017 Q1 | - IDR | 0.0% |
2017 Q2 | - IDR | 0.0% |
2017 Q3 | - IDR | 0.0% |
2017 Q4 | - IDR | 0.0% |
2017 FY | - IDR | 0.0% |
2016 Q3 | - IDR | 0.0% |
2016 FY | - IDR | 0.0% |
2016 Q4 | - IDR | 0.0% |
2016 Q2 | - IDR | 0.0% |
2016 Q1 | - IDR | 0.0% |
2015 Q1 | - IDR | 0.0% |
2015 FY | - IDR | 0.0% |
2015 Q4 | - IDR | 0.0% |
2015 Q3 | - IDR | 0.0% |
2015 Q2 | - IDR | 0.0% |
2014 Q4 | - IDR | 0.0% |
2014 Q3 | - IDR | 0.0% |
2014 Q2 | - IDR | 0.0% |
2014 Q1 | - IDR | 0.0% |
2014 FY | - IDR | 0.0% |
2013 Q2 | - IDR | 0.0% |
2013 Q1 | - IDR | 0.0% |
2013 FY | - IDR | 0.0% |
2013 Q4 | - IDR | 0.0% |
2012 FY | - IDR | -100.0% |
2011 FY | 252.98 Billion IDR | 7.26% |
2010 FY | 235.85 Billion IDR | 5.38% |
2009 FY | 223.81 Billion IDR | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
PT Darya-Varia Laboratoria Tbk | 1.04 Billion IDR | -216.163% |
PT Merck Tbk | 11.19 Billion IDR | 70.525% |
PT Phapros, Tbk | 162.65 Billion IDR | 97.971% |
PT Pyridam Farma Tbk | 830.4 Billion IDR | 99.603% |
PT Tempo Scan Pacific Tbk | 70.73 Billion IDR | 95.335% |